“The present predicament has uncovered some structural weaknesses inside the EU’s medicines source chain as well as a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She advised that provide chain concerns be addressed within an EU pharmaceutical system anticipated to generally be introduced b